Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Gardner

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer Gene Therapy|October 3, 2009
Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAILJ A Jiménez, X Li, Y-P Zhang, et al.
International Journal of Cancer|October 23, 2001
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cellsT Shirakawa, R Sasaki, T A Gardner, et al.
The Journal of Urology|August 24, 1999
Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma modelT Shirakawa, T A Gardner, S C Ko, et al.
Cancer Gene Therapy|September 6, 2008
Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoterM Ahn, S-J Lee, X Li, et al.
British Journal of Cancer|June 2, 2005
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivationC Jung, R-S Kim, H Zhang, et al.
The Journal of Gene Medicine|February 24, 2001
p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat modelT Shirakawa, A Gotoh, T A Gardner, et al.
World Journal of Urology|June 15, 2000
Osteocalcin-directed gene therapy for prostate-cancer bone metastasisK S Koeneman, C Kao, S C Ko, et al.
Cancer Research|August 17, 2001
A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasisS Matsubara, Y Wada, T A Gardner, et al.
The Journal of Urology|June 17, 1998
Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancerA Gotoh, S C Ko, T Shirakawa, et al.
Science (New York, N.Y.)|November 8, 2014
Environment and Development. Brazil's environmental leadership at riskJ Ferreira, L E O C Aragão, J Barlow, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Gene Therapy|October 3, 2009
Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAILJ A Jiménez, X Li, Y-P Zhang, et al.
International Journal of Cancer|October 23, 2001
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cellsT Shirakawa, R Sasaki, T A Gardner, et al.
The Journal of Urology|August 24, 1999
Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma modelT Shirakawa, T A Gardner, S C Ko, et al.
Cancer Gene Therapy|September 6, 2008
Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoterM Ahn, S-J Lee, X Li, et al.
British Journal of Cancer|June 2, 2005
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivationC Jung, R-S Kim, H Zhang, et al.
The Journal of Gene Medicine|February 24, 2001
p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat modelT Shirakawa, A Gotoh, T A Gardner, et al.
World Journal of Urology|June 15, 2000
Osteocalcin-directed gene therapy for prostate-cancer bone metastasisK S Koeneman, C Kao, S C Ko, et al.
Cancer Research|August 17, 2001
A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasisS Matsubara, Y Wada, T A Gardner, et al.
The Journal of Urology|June 17, 1998
Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancerA Gotoh, S C Ko, T Shirakawa, et al.
Science (New York, N.Y.)|November 8, 2014
Environment and Development. Brazil's environmental leadership at riskJ Ferreira, L E O C Aragão, J Barlow, et al.
Pageof 4